Cipla Q3 Results FY25–26: Net Profit ₹674 Cr, Down 57.2% YoY, Revenue ₹7,074 Crore

    Synopsis:


    Cipla reported consolidated revenue from operations of ₹7,074.48 crore in Q3 FY25–26, broadly flat YoY. Net profit stood at ₹674.25 crore, reflecting a decline compared to the year-ago quarter, impacted by exceptional items, as per its exchange filing.

    Cipla announced its unaudited consolidated financial results on 23 January 2026 for the quarter ended December 31, 2025 (Q3 FY25–26). The company reported stable revenue performance, while profitability declined on a year-on-year basis due to lower operating profit and an exceptional loss during the quarter.

    On a consolidated basis, revenue from operations stood at ₹7,074.48 crore, while net profit for the quarter came in at ₹674.25 crore.

    Cipla Q3 Results FY25–26 Date & Announcement

    Cipla declared its Q3 FY25–26 financial results on 23 January 2026, covering the consolidated performance for the quarter ended December 31, 2025, as disclosed through its stock exchange filing.

    Cipla Ltd

    Trade

    1463.8-13.19 (-0.89 %)

    Updated - 07 August 2026
    1477.00day high
    DAY HIGH
    1462.10day low
    DAY LOW
    765193
    VOLUME (BSE)

    Cipla Q3 Results FY25–26 – Key Financial Highlights (Consolidated)

    All figures in ₹ crore | Consolidated | Unaudited

    Particulars

    Q3 FY25–26

    Q2 FY25–26

    Q3 FY24–25

    YoY %

    QoQ %

    Revenue from the Sale of Products

    6,962.97

    7,447.42

    6,961.60

    0.0%

    (6.5%)

    Other Operating Revenue

    111.51

    142.02

    111.37

    0.1%

    (21.5%)

    Total Revenue from Operations

    7,074.48

    7,589.44

    7,072.97

    0.0%

    (6.8%)

    Other Income

    206.34

    268.95

    221.61

    (6.9%)

    (23.3%)

    Total Income

    7,280.82

    7,858.39

    7,294.58

    (0.2%)

    (7.3%)

    Total Expenses

    6,111.80

    6,004.86

    5,378.49

    13.6%

    1.8%

    Profit Before Exceptional Items & Tax

    1,169.02

    1,853.53

    1,916.09

    (39.0%)

    (36.9%)

    Exceptional Item (Loss)

    (275.91)

    Profit Before Tax (PBT)

    893.11

    1,853.53

    1,916.09

    (53.4%)

    (51.8%)

    Tax Expense (Net)

    218.55

    500.46

    332.37

    (34.2%)

    (56.3%)

    Net Profit (PAT)

    674.25

    1,353.37

    1,574.59

    (57.2%)

    (50.2%)

    EPS – Basic (₹)

    8.37

    16.73

    19.45

    (57.0%)

    (50.0%)

    EPS – Diluted (₹)

    8.36

    16.72

    19.43

    (57.0%)

    (50.0%)

    Cipla Q3 FY25–26 vs Q2 FY25–26 – Comparison (Consolidated)

    All figures in ₹ crore | Consolidated | Unaudited

    Particulars

    Q3 FY25–26

    Q2 FY25–26

    QoQ Change

    Total Revenue from Operations

    7,074.48

    7,589.44

    (6.8%)

    Other Income

    206.34

    268.95

    (23.3%)

    Total Income

    7,280.82

    7,858.39

    (7.3%)

    Total Expenses

    6,111.80

    6,004.86

    1.8%

    Profit Before Tax (PBT)

    893.11

    1,853.53

    (51.8%)

    Tax Expense (Net)

    218.55

    500.46

    (56.3%)

    Net Profit (PAT)

    674.25

    1,353.37

    (50.2%)

    EPS – Basic (₹)

    8.37

    16.73

    (50.0%)

    EPS – Diluted (₹)

    8.36

    16.72

    (50.0%)

    On a quarter-on-quarter basis, Cipla reported a decline in profitability as revenue moderated sequentially while costs remained elevated, resulting in lower earnings during the quarter.

    Cipla Q3 Business Segment Performance (Consolidated)

    Figures are consolidated, unaudited, and represent Q3 FY25–26 only.

    Segment Revenue (₹ Cr)

    Segment

    Q3 FY25–26 Revenue

    Q2 FY25–26 Revenue

    Q3 FY24–25 Revenue

    Pharmaceuticals

    6,746.40

    7,291.43

    6,777.84

    New Ventures

    381.48

    350.68

    341.30

    Total Segment Revenue

    7,127.88

    7,642.11

    7,119.14

    Less: Inter-segment Revenue

    (53.40)

    (52.67)

    (46.17)

    Total Revenue from Operations

    7,074.48

    7,589.44

    7,072.97

    Segment Result / PBT (₹ Cr)

    Segment

    Q3 FY25–26 Segment Result

    Q2 FY25–26 Segment Result

    Q3 FY24–25 Segment Result

    Pharmaceuticals

    1,122.26

    1,825.49

    1,888.86

    New Ventures

    60.79

    41.22

    41.87

    Total Segment Result

    1,183.05

    1,866.71

    1,930.73

    Less: Finance Costs

    14.03

    13.18

    14.64

    Profit Before Exceptional Items & Tax

    1,169.02

    1,853.53

    1,916.09

    Less: Exceptional Item (Loss)

    275.91

    Profit Before Tax (PBT)

    893.11

    1,853.53

    1,916.09

    Pharmaceuticals remained the largest contributor to consolidated revenue and profitability during the quarter, while New Ventures contributed a smaller share of revenue and profit.

    Market Reaction After Cipla Q3 Results FY25–26

    Cipla released its quarterly results during market hours. As of 2 PM IST on 23 January 2026, Cipla’s share price is trading at ₹1311.55 on the NSE, down by 4.37%.

    Conclusion – What Cipla Q3 Results Indicate

    Cipla’s Q3 FY25–26 results indicate declining operating revenue but a decline in net profit on both a year-on-year and quarter-on-quarter basis. The performance reflects pressure on profitability during the quarter, along with the impact of an exceptional loss.

    For more quarterly result updates, visit Bajaj Broking’s Quarterly Results Calendar.

    Share this article: 

    Frequently Asked Questions

    Disclaimer :

    Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Publish Date: 23 Jan 2026

    Our Secure Trading Platforms

    Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    1 M+ Users

    4.8 App Rating

    4 Languages

    ₹7,300 Cr+ MTF Book

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |